Intravenous antiplatelet therapies (glycoprotein IIb/IIIa receptor inhibitors and cangrelor) in percutaneous coronary intervention: from pharmacology to indications for clinical use

Oral antiplatelet drugs are crucially important for patients with acute coronary syndrome or stable coronary artery disease undergoing percutaneous coronary intervention (PCI). In recent decades, several clinical trials have focused on reducing periprocedural ischemic events in patients undergoing P...

Full description

Saved in:
Bibliographic Details
Published in:Ther Adv Cardiovasc Dis
Main Authors: Capodanno, Davide, Milluzzo, Rocco P., Angiolillo, Dominick J.
Format: Artigo
Language:Inglês
Published: SAGE Publications 2019
Subjects:
Review
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6906352/
https://ncbi.nlm.nih.gov/pubmed/31823688
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1753944719893274
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items